Tata Motors, Lupin, GAIL, Cipla and Sun Pharma are top gainers while Coal India, Bharti Airtel, TCS, Wipro and Asian Paints are losers in the Sensex.
Drug major Lupin said its US arm Gavis has received approval from the US health regulator to market Hydrocodone Bitartrate and Acetaminophen tablets, a pain relieving drug, in the American market.
Gavis Pharmaceuticals, a subsidiary of the company, has has received final approval for its Hydrocodone Bitartrate and Acetaminophen tablets from the US Food and Drug Administration (USFDA), Lupin said in a statement.
